. Engineering anti-amyloid antibodies with transferrin receptor targeting improves safety and brain biodistribution. 2024 Jul 26 10.1101/2024.07.26.604664 (version 1) bioRxiv.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Tweaked, Aβ-Antibodies Cross Blood-Brain ‘Border’ (Bye-Bye, Barrier?)